Bb5a31f81ClaimResearch presented at the IEEE Electronic Components and Technology Conference demonstrated hybrid-bonded devices functioning at a 0.45-micrometer pitchAgreeDisagree
Bb5a31f81ClaimFinFET was demonstrated in a laboratory in 1989 and reached volume production at Intel in 2011AgreeDisagree
Bb5a31f81ClaimIntel researchers prototype simplified CFET vehicles consisting of one NMOS wire and one PMOS wire to evaluate device stackingAgreeDisagree
Bb5a31f81ClaimSpencer McIntyre transitioned into exploit research and development after working in cybersecurity consultingAgreeDisagree
Bb5a31f81ClaimPreclinical mouse studies and molecule discovery typically cost 50 million dollars and take two to three years of drug developmentAgreeDisagree
Bb5a31f81ClaimDeveloping a commercial drug typically takes 15 years and costs approximately 1.5 billion dollarsAgreeDisagree
Bb5a31f81ClaimClinical trials typically account for more than 1.4 billion dollars and 12 years of drug development costsAgreeDisagree
Bb5a31f81ClaimIn pharmaceutical drug development, preclinical mouse studies typically cost around $50 million over two to three yearsAgreeDisagree
Bb5a31f81ClaimIn pharmaceutical drug development, clinical trials typically cost over $1.4 billion and span approximately 12 yearsAgreeDisagree
Bb5a31f81ClaimDeveloping a new pharmaceutical drug typically requires approximately 15 years and $1.5 billionAgreeDisagree
Bb5a31f81ClaimBringing a single successful drug candidate from early discovery through clinical approval costs between $200 million and over $1 billionAgreeDisagree
Bb5a31f81ClaimThe goal of Trillium's transparent documentation of its RSI work is to give policymakers and the public a more grounded understanding of AI capabilitiesAgreeDisagree
Bb5a31f81ClaimIn October 2026, a separate academic initiative called "open RSI" was launched with goals similar to Trillium'sAgreeDisagree
Bb5a31f81ClaimThe risks from current AI capabilities that are diffusing throughout society are more pressing than potential future risks from Recursive Self-ImprovementAgreeDisagree
Bb5a31f81ClaimThe nonprofit lab Trillium plans to demystify Recursive Self-Improvement by publicly sharing the tools, tasks, and configurations it usesAgreeDisagree
Bb5a31f81ClaimThe nonprofit lab Trillium intends to transparently document how AI is used to improve AIAgreeDisagree
Bb5a31f81ClaimThe concept of Recursive Self-Improvement (RSI) in AI is surrounded by a great deal of mystiqueAgreeDisagree
Bb5a31f81ClaimAlan Chan advocates for measuring the extent of AI R&D automation, its effect on the acceleration of AI progress, and any resulting oversight problemsAgreeDisagree
Bb5a31f81ClaimA paper by Alan Chan and co-authors on automated AI R&D argues that handing AI research to AIs could lead to unpredictable outcomes and a loss of controlAgreeDisagree
Bb5a31f81ClaimCo-authors of Alan Chan's paper on the possibility that automated AI R&D could trigger an intelligence explosion included Jakob Pachocki, Jack Clark, Geoffrey Hinton, and Yoshua BengioAgreeDisagree